Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?

Patients with antiphospholipid syndrome (APS) are at increased risk of recurrent thromboembolic events due to the pathology of the disease. While prolonged anticoagulation is the treatment of choice for patients with thrombosis, much debate remains about the optimum intensity of anticoagulation. Ant...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cureus
Main Authors: Kim, Esther, Do, Tiffanie, Peacock, Katie, Takundwa, Prisca T
Formato: Artigo
Idioma:Inglês
Publicado em: Cureus 2016
Assuntos:
Rheumatology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045335/
https://ncbi.nlm.nih.gov/pubmed/27725921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.765
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados